Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Gastroesophageal Junction”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00259987
What this trial is testing

Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus

Who this might be right for
Adenocarcinoma
GlaxoSmithKline 24
Large-scale testing (Phase 3)Active Not RecruitingNCT06356311
What this trial is testing

Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)

Who this might be right for
Gastroesophageal Cancer
Merck Sharp & Dohme LLC 450
Testing effectiveness (Phase 2)Study completedNCT01504256
What this trial is testing

Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas

Who this might be right for
Gastric Adenocarcinoma With Peritoneal CarcinomatosisSiewert Type II Adenocarcinoma of Esophagogastric Junction With Peritoneal CarcinomatosisSiewert Type III Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis
AIO-Studien-gGmbH 42
Testing effectiveness (Phase 2)Ended earlyNCT03840967
What this trial is testing

A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma

Who this might be right for
Esophageal CancerGastric CancerAdenocarcinoma
Shadia Jalal, MD 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05095467
What this trial is testing

HIPEC-AS in Patients With Peritoneal Metastasis of the Stomach or Esophagogastric Junction

Who this might be right for
Stomach NeoplasmsPeritoneal Metastases
Xuefei.Wang 157
Testing effectiveness (Phase 2)Ended earlyNCT04604132
What this trial is testing

Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma

Who this might be right for
Gastric Adenocarcinoma
Basilea Pharmaceutica 47
Testing effectiveness (Phase 2)UnknownNCT04890392
What this trial is testing

Tislelizumab Combined With S-1 Plus Oxaliplatin as a Neoadjuvant Treatment in Patients With GC/GEJC

Who this might be right for
Advanced Gastric CancerAdvanced Gastroesophageal Junction Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 20
Testing effectiveness (Phase 2)Study completedNCT00096031
What this trial is testing

S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
SWOG Cancer Research Network 63
Large-scale testing (Phase 3)Study completedNCT04882241
What this trial is testing

Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
Merck Sharp & Dohme LLC 120
Testing effectiveness (Phase 2)UnknownNCT05994456
What this trial is testing

Neoadjuvant Toripalimab for dMMR/MSI-H Gastric Cancer

Who this might be right for
Gastric or Gastroesophageal Junction Adenocarcinoma
Sun Yat-sen University 24
Testing effectiveness (Phase 2)Ended earlyNCT01395537
What this trial is testing

Lapatinib With Carboplatin and Paclitaxel in Esophagus and Gastroesophageal Junction (GEJ)

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal Junction
Case Comprehensive Cancer Center 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT07776639
What this trial is testing

Iparomlimab and Tuvonralimab Injection (QL1706) Combined With DOS as Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction

Who this might be right for
Gastroesophageal Junction AdenocarcinomaGastric Adenocarcinoma
Yongxu Jia 34
Early research (Phase 1)UnknownNCT03276156
What this trial is testing

Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Zhejiang Cancer Hospital 12
Testing effectiveness (Phase 2)UnknownNCT05739045
What this trial is testing

Nivolumab Combined With SOX Used in the Perioperative Treatment

Who this might be right for
Immune SuppressionGastric Cancer
Xiangdong Cheng 46
Testing effectiveness (Phase 2)Looking for participantsNCT06163729
What this trial is testing

Camrelizumab Combined With Chemotherapy and Radiotherapy Perioperative Treatment of Esophageal Gastric Junction Adenocarcinoma

Who this might be right for
Gastroesophageal Junction Adenocarcinoma (Siewert II-III)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 68
Large-scale testing (Phase 3)Not Yet RecruitingNCT07716449
What this trial is testing

QLS31905 in Combination With CAPOX Versus Sintilimab in Combination With CAPOX as First-line Treatment in Patients With GC/GEJ

Who this might be right for
Gastric or Gastroesophageal Junction Adenocarcinoma
Qilu Pharmaceutical Co., Ltd. 560
Large-scale testing (Phase 3)Not Yet RecruitingNCT06093425
What this trial is testing

Combination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma

Who this might be right for
Gastric CancerGastroesophageal-junction CancerAdvanced Cancer
Transcenta Therapeutics (Hangzhou) Co., Ltd. 820
Testing effectiveness (Phase 2)UnknownNCT04631757
What this trial is testing

Conversion Therapy of Camrelizumab Plus Chemoradiotherapy in Participants With Initial Unresectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Who this might be right for
Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital 33
Early research (Phase 1)Not Yet RecruitingNCT06748872
What this trial is testing

EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma

Who this might be right for
Epithelial Ovarian CancerGastro-esophageal Junction CancerSoft Tissue Sarcoma (STS)+2 more
Medigene AG 55
Not applicableApproved For MarketingNCT02065765
What this trial is testing

International Expanded Access Program to Provide Ramucirumab for the Treatment of Metastatic Gastric Cancer

Who this might be right for
Metastatic Gastric CancerMetastatic Adenocarcinoma of the Gastroesophageal Junction
Eli Lilly and Company
Next Page